{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:10:59Z","timestamp":1790964659587,"version":"4.1.0"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Matrouh University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Type 2 diabetes (T2D) accounts for over 90% of diabetes mellitus and is characterized by peripheral tissue insulin resistance, a defective compensatory insulin secretion, and reduced insulin output from pancreatic <jats:italic>\u03b2<\/jats:italic>-cells. T2D is a complex metabolic syndrome involving multiple cell types within multiple organs, such as the liver, muscle, adipose tissue, and pancreas. Because the adult human endocrine pancreas does not have regenerative capability, understanding of the pathogenesis of T2D is vital for working out successful strategies for the delay or arrest of disease development. Newly, ferroptosis, an iron-dependent, regulated cell death, has emerged as a significant promoter of the pathogenesis and development of T2D. Ferroptosis is distinguishable from apoptosis, autophagy, and necroptosis, and is characterized by the accumulation of iron, lipid peroxidation, and suppression of glutathione peroxidase 4 (GPX4). Ferroptosis in pancreatic \u03b2-cells results in the defective secretion of insulin. The labile iron pool (LIP), particularly Fe<jats:sup>2<\/jats:sup>\u207a, enhances the formation of reactive oxygen species (ROS) during the Fenton reaction, thereby leading to ferroptosis. Recent empirical studies have revealed an exquisite regulatory interaction between ferroptosis and microRNAs (miRNAs), with the implication being that miRNAs play a central role in the regulation of ferroptosis during T2D. Two-way regulation of ferroptosis by miRNAs has been highlighted herein, with special focus on new insights and the speculation on the potential of using inhibition of ferroptosis as a strategy for treatment. Therapeutic approaches targeting ferroptosis include the use of ferroptosis inhibitors, such as Ferrostatin-1 and Deferoxamine, and miRNA-guided therapy that regulates iron homeostasis and lipid peroxidation. Such interventions may find practical applications in sustaining <jats:italic>\u03b2<\/jats:italic>-cell function and stimulating insulin secretion in diabetic patients. In conclusion, understanding the molecular mechanisms that regulate ferroptosis and identifying specific drugs targeting ferroptosis and associated miRNAs may unlock novel and effective therapies for individuals with T2D.<\/jats:p>","DOI":"10.1186\/s40001-025-03178-y","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T02:10:23Z","timestamp":1760580623000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Crosstalk between ferroptosis and miRNA in type 2 diabetes mellitus and possible therapeutic targeting"],"prefix":"10.1186","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9555-7300","authenticated-orcid":false,"given":"Hebatallah M.","family":"Saad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa A.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omnya","family":"Elhussieny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5988-6883","authenticated-orcid":false,"given":"Tasnim S.","family":"Waheeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer E.","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"issue":"1","key":"3178_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4239\/wjd.v7.i1.1","volume":"7","author":"M Karamanou","year":"2016","unstructured":"Karamanou M, Protogerou A, Tsoucalas G, Androutsos G, Poulakou-Rebelakou E. Milestones in the history of diabetes mellitus: the main contributors. World J Diabetes. 2016;7(1):1.","journal-title":"World J Diabetes"},{"issue":"2","key":"3178_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2337\/dc22-0945","volume":"46","author":"T T\u00f6nnies","year":"2023","unstructured":"T\u00f6nnies T, Brinks R, Isom S, Dabelea D, Divers J, Mayer-Davis EJ, et al. Projections of type 1 and type 2 diabetes burden in the US population aged< 20 years through 2060: the SEARCH for diabetes in youth study. Diabetes Care. 2023;46(2):313\u201320.","journal-title":"Diabetes Care"},{"key":"3178_CR3","unstructured":"Control CfD Prevention. National diabetes statistics report 2020: estimates of diabetes and its burden in the United States. 2022; 2023."},{"key":"3178_CR4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2016.PA514","author":"S Zunic","year":"2016","unstructured":"Zunic S, Zunic S. Feroptosis of alveolar macrophages in lung cancer. Eur Respiratory Soc. 2016. https:\/\/doi.org\/10.1183\/13993003.congress-2016.PA514.","journal-title":"Eur Respiratory Soc"},{"issue":"6","key":"3178_CR5","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210518","volume":"218","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Ferroptosis in infection, inflammation, and immunity. J Exp Med. 2021;218(6):e20210518.","journal-title":"J Exp Med"},{"issue":"6","key":"3178_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2023.5256","volume":"51","author":"DKW Ocansey","year":"2023","unstructured":"Ocansey DKW, Yuan J, Wei Z, Mao F, Zhang Z. Role of ferroptosis in the pathogenesis and as a therapeutic target of inflammatory bowel disease. Int J Mol Med. 2023;51(6):1\u201316.","journal-title":"Int J Mol Med"},{"issue":"1","key":"3178_CR7","first-page":"9999612","volume":"2021","author":"W Sha","year":"2021","unstructured":"Sha W, Hu F, Xi Y, Chu Y, Bu S. Mechanism of ferroptosis and its role in type 2 diabetes mellitus. J Diabetes Res. 2021;2021(1):9999612.","journal-title":"J Diabetes Res"},{"issue":"1","key":"3178_CR8","first-page":"8010614","volume":"2019","author":"Z Hu","year":"2019","unstructured":"Hu Z, Zhang H, Yang S-k, Wu X, He D, Cao K, et al. Emerging role of ferroptosis in acute kidney injury. Oxid Med Cell Longev. 2019;2019(1):8010614.","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"3178_CR9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, et al. Ferroptosis: process and function. Cell Death Differ. 2016;23(3):369\u201379.","journal-title":"Cell Death Differ"},{"issue":"2","key":"3178_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin H-l, Huang Z-j, Lin Z-t, Mao N, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3178_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-01825-7","volume":"10","author":"X Jin","year":"2024","unstructured":"Jin X, Tang J, Qiu X, Nie X, Ou S, Wu G, et al. Ferroptosis: emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation. Cell Death Discov. 2024;10(1):45.","journal-title":"Cell Death Discov"},{"issue":"8","key":"3178_CR12","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cmet.2022.07.006","volume":"34","author":"H Gao","year":"2022","unstructured":"Gao H, Jin Z, Bandyopadhyay G, Wang G, Zhang D, Rocha KCE, et al. Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis. Cell Metab. 2022;34(8):1201\u201313.","journal-title":"Cell Metab"},{"issue":"8","key":"3178_CR13","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.cmet.2021.06.001","volume":"33","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Funcke J-B, Zi Z, Zhao S, Straub LG, Zhu Y, et al. Adipocyte iron levels impinge on a fat-gut crosstalk to regulate intestinal lipid absorption and mediate protection from obesity. Cell Metab. 2021;33(8):1624\u201339.","journal-title":"Cell Metab"},{"issue":"2","key":"3178_CR14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1210\/jc.2017-01706","volume":"103","author":"OP Zaharia","year":"2018","unstructured":"Zaharia OP, Bobrov P, Strassburger K, Bodis K, Karusheva Y, Scholz M, et al. Metabolic characteristics of recently diagnosed adult-onset autoimmune diabetes mellitus. J Clin Endocrinol Metab. 2018;103(2):429\u201337.","journal-title":"J Clin Endocrinol Metab"},{"key":"3178_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00125-004-1625-y","volume":"48","author":"T Drivsholm","year":"2005","unstructured":"Drivsholm T, de Fine ON, Nielsen A, Siersma V. Symptoms, signs and complications in newly diagnosed type 2 diabetic patients, and their relationship to glycaemia, blood pressure and weight. Diabetologia. 2005;48:210\u20134.","journal-title":"Diabetologia"},{"issue":"7566","key":"3178_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1136\/bmj.38922.650521.80","volume":"333","author":"SM Marshall","year":"2006","unstructured":"Marshall SM, Flyvbjerg A. Prevention and early detection of vascular complications of diabetes. BMJ. 2006;333(7566):475\u201380.","journal-title":"BMJ"},{"issue":"11","key":"3178_CR17","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.2337\/dc14-0984","volume":"37","author":"FJ Pasquel","year":"2014","unstructured":"Pasquel FJ, Umpierrez GE. Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. Diabetes Care. 2014;37(11):3124\u201331.","journal-title":"Diabetes Care"},{"issue":"2","key":"3178_CR18","first-page":"99","volume":"37","author":"OA Fasanmade","year":"2008","unstructured":"Fasanmade OA, Odeniyi IA, Ogbera AO. Diabetic ketoacidosis: diagnosis and management. Afr J Med Med Sci. 2008;37(2):99\u2013105.","journal-title":"Afr J Med Med Sci"},{"issue":"1","key":"3178_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.19","volume":"1","author":"RA DeFronzo","year":"2015","unstructured":"DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015;1(1):1\u201322.","journal-title":"Nat Rev Dis Primers"},{"key":"3178_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-021-05466-2","volume":"14","author":"P Kulkarni","year":"2021","unstructured":"Kulkarni P, Devkumar P, Chattopadhyay I. Could dysbiosis of inflammatory and anti-inflammatory gut bacteria have an implications in the development of type 2 diabetes? A pilot investigation. BMC Res Notes. 2021;14:1\u20137.","journal-title":"BMC Res Notes"},{"issue":"7612","key":"3178_CR21","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature18646","volume":"535","author":"HK Pedersen","year":"2016","unstructured":"Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BA, et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016;535(7612):376\u201381.","journal-title":"Nature"},{"issue":"5","key":"3178_CR22","first-page":"1081","volume":"61","author":"ST Mackin","year":"2018","unstructured":"Mackin ST, Nelson SM, Kerssens JJ, Wood R, Wild S, Colhoun HM, et al. Diabetes and pregnancy: national trends over a 15 year period. Diabetologia. 2018;61(5):1081\u20138.","journal-title":"Diabetologia"},{"issue":"5","key":"3178_CR23","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.athoracsur.2009.11.033","volume":"89","author":"H Tekumit","year":"2010","unstructured":"Tekumit H, Cenal AR, Polat A, Uzun K, Tataroglu C, Akinci E. Diagnostic value of hemoglobin A1c and fasting plasma glucose levels in coronary artery bypass grafting patients with undiagnosed diabetes mellitus. Ann Thorac Surg. 2010;89(5):1482\u20137.","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"3178_CR24","doi-asserted-by":"publisher","DOI":"10.4103\/2277-9531.127541","volume":"3","author":"M Asif","year":"2014","unstructured":"Asif M. The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern. J Educ Health Promot. 2014;3(1):1.","journal-title":"J Educ Health Promot"},{"key":"3178_CR25","doi-asserted-by":"publisher","DOI":"10.4137\/CMT.S1085","author":"N Papanas","year":"2009","unstructured":"Papanas N, Maltezos E. Metformin: a review of its use in the treatment of type 2 diabetes. Clinical Medicine Therapeutics. 2009. https:\/\/doi.org\/10.4137\/CMT.S1085.","journal-title":"Clinical Medicine Therapeutics"},{"issue":"5","key":"3178_CR26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1056\/NEJMoa021778","volume":"348","author":"P G\u00e6de","year":"2003","unstructured":"G\u00e6de P, Vedel P, Larsen N, Jensen GV, Parving H-H, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5):383\u201393.","journal-title":"N Engl J Med"},{"issue":"2","key":"3178_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88\u201398.","journal-title":"Nat Rev Endocrinol"},{"key":"3178_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2013.00037","volume":"4","author":"ME Cerf","year":"2013","unstructured":"Cerf ME. Beta cell dysfunction and insulin resistance. Front Endocrinol. 2013;4:37.","journal-title":"Front Endocrinol"},{"issue":"11","key":"3178_CR29","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1056\/NEJMoa010492","volume":"345","author":"FB Hu","year":"2001","unstructured":"Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345(11):790\u20137.","journal-title":"N Engl J Med"},{"issue":"8","key":"3178_CR30","doi-asserted-by":"publisher","first-page":"543","DOI":"10.7326\/0003-4819-159-8-201310150-00007","volume":"159","author":"ES Schellenberg","year":"2013","unstructured":"Schellenberg ES, Dryden DM, Vandermeer B, Ha C, Korownyk C. Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med. 2013;159(8):543\u201351.","journal-title":"Ann Intern Med"},{"issue":"9467","key":"3178_CR31","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/S0140-6736(05)61032-X","volume":"365","author":"M Stumvoll","year":"2005","unstructured":"Stumvoll M, Goldstein BJ, Van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365(9467):1333\u201346.","journal-title":"Lancet"},{"issue":"6","key":"3178_CR32","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI7231","volume":"104","author":"C Weyer","year":"1999","unstructured":"Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest. 1999;104(6):787\u201394.","journal-title":"J Clin Invest"},{"issue":"4","key":"3178_CR33","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2337\/db09-9028","volume":"58","author":"RA DeFronzo","year":"2009","unstructured":"DeFronzo RA. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58(4):773\u201395.","journal-title":"Diabetes"},{"issue":"2","key":"3178_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2337\/dc15-1585","volume":"39","author":"SS Schwartz","year":"2016","unstructured":"Schwartz SS, Epstein S, Corkey BE, Grant SF, Gavin JR III, Aguilar RB. The time is right for a new classification system for diabetes: rationale and implications of the \u03b2-cell\u2013centric classification schema. Diabetes Care. 2016;39(2):179\u201386.","journal-title":"Diabetes Care"},{"key":"3178_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.physbeh.2017.03.040","volume":"176","author":"P Bunney","year":"2017","unstructured":"Bunney P, Zink A, Holm A, Billington C, Kotz C. Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet. Physiol Behav. 2017;176:139\u201348.","journal-title":"Physiol Behav"},{"issue":"1","key":"3178_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2174\/157339913804143225","volume":"9","author":"Z Fu","year":"2013","unstructured":"Fu Z, Gilbert ER, Liu D. Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr Diabetes Rev. 2013;9(1):25\u201353.","journal-title":"Curr Diabetes Rev"},{"issue":"9","key":"3178_CR37","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.molmet.2017.04.010","volume":"6","author":"BB Boland","year":"2017","unstructured":"Boland BB, Rhodes CJ, Grimsby JS. The dynamic plasticity of insulin production in \u03b2-cells. Mol Metab. 2017;6(9):958\u201373.","journal-title":"Mol Metab"},{"issue":"1","key":"3178_CR38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1152\/physrev.00008.2017","volume":"98","author":"P Rorsman","year":"2018","unstructured":"Rorsman P, Ashcroft FM. Pancreatic \u03b2-cell electrical activity and insulin secretion: of mice and men. Physiol Rev. 2018;98(1):117\u2013214.","journal-title":"Physiol Rev"},{"issue":"17","key":"3178_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176275","volume":"21","author":"U Galicia-Garcia","year":"2020","unstructured":"Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275.","journal-title":"Int J Mol Sci"},{"issue":"6779","key":"3178_CR40","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/35008121","volume":"404","author":"T Nishikawa","year":"2000","unstructured":"Nishikawa T, Edelstein D, Du XL, Yamagishi S-i, Matsumura T, Kaneda Y, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404(6779):787\u201390.","journal-title":"Nature"},{"issue":"5","key":"3178_CR41","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jdiacomp.2004.03.002","volume":"18","author":"RA Kowluru","year":"2004","unstructured":"Kowluru RA, Abbas SN, Odenbach S. Reversal of hyperglycemia and diabetic nephropathy: effect of reinstitution of good metabolic control on oxidative stress in the kidney of diabetic rats. J Diabetes Complic. 2004;18(5):282\u20138.","journal-title":"J Diabetes Complic"},{"key":"3178_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2007\/21976","author":"RA Kowluru","year":"2007","unstructured":"Kowluru RA, Kanwar M, Kennedy A. Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries. J Diabetes Res. 2007. https:\/\/doi.org\/10.1155\/2007\/21976.","journal-title":"J Diabetes Res"},{"issue":"2","key":"3178_CR43","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1210\/jc.2008-1824","volume":"94","author":"A Ceriello","year":"2009","unstructured":"Ceriello A, Ihnat MA, Thorpe JE. The \u201cmetabolic memory\u201d: is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab. 2009;94(2):410\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3178_CR44","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/cvr\/cvr024","volume":"90","author":"MA Reddy","year":"2011","unstructured":"Reddy MA, Natarajan R. Epigenetic mechanisms in diabetic vascular complications. Cardiovasc Res. 2011;90(3):421\u20139.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"3178_CR45","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41419-023-05708-0","volume":"14","author":"R Miao","year":"2023","unstructured":"Miao R, Fang X, Zhang Y, Wei J, Zhang Y, Tian J. Iron metabolism and ferroptosis in type 2 diabetes mellitus and complications: mechanisms and therapeutic opportunities. Cell Death Dis. 2023;14(3):186.","journal-title":"Cell Death Dis"},{"issue":"3","key":"3178_CR46","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","volume":"3","author":"S Dolma","year":"2003","unstructured":"Dolma S, Lessnick SL, Hahn WC, Stockwell BR. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003;3(3):285\u201396.","journal-title":"Cancer Cell"},{"issue":"5","key":"3178_CR47","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"4","key":"3178_CR48","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.cell.2011.10.033","volume":"147","author":"Y Fuchs","year":"2011","unstructured":"Fuchs Y, Steller H. Programmed cell death in animal development and disease. Cell. 2011;147(4):742\u201358.","journal-title":"Cell"},{"issue":"5203","key":"3178_CR49","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1126\/science.7878464","volume":"267","author":"CB Thompson","year":"1995","unstructured":"Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267(5203):1456\u201362.","journal-title":"Science"},{"issue":"3","key":"3178_CR50","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/febs.14186","volume":"285","author":"A Pe\u00f1a-Blanco","year":"2018","unstructured":"Pe\u00f1a-Blanco A, Garc\u00eda-S\u00e1ez AJ. Bax, Bak and beyond\u2014mitochondrial performance in apoptosis. FEBS J. 2018;285(3):416\u201331.","journal-title":"FEBS J"},{"issue":"7545","key":"3178_CR51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520(7545):57\u201362.","journal-title":"Nature"},{"issue":"7146","key":"3178_CR52","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nature05859","volume":"447","author":"N Yagoda","year":"2007","unstructured":"Yagoda N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ, et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature. 2007;447(7146):864\u20138.","journal-title":"Nature"},{"issue":"2","key":"3178_CR53","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41419-022-04628-9","volume":"13","author":"L Ni","year":"2022","unstructured":"Ni L, Yuan C, Wu X. Targeting ferroptosis in acute kidney injury. Cell Death Dis. 2022;13(2):182.","journal-title":"Cell Death Dis"},{"key":"3178_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106086","volume":"176","author":"L Chen","year":"2022","unstructured":"Chen L, Yin Z, Qin X, Zhu X, Chen X, Ding G, et al. CD74 ablation rescues type 2 diabetes mellitus-induced cardiac remodeling and contractile dysfunction through pyroptosis-evoked regulation of ferroptosis. Pharmacol Res. 2022;176:106086.","journal-title":"Pharmacol Res"},{"issue":"13","key":"3178_CR55","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1089\/ars.2021.0233","volume":"37","author":"W Tang","year":"2022","unstructured":"Tang W, Li Y, He S, Jiang T, Wang N, Du M, et al. Caveolin-1 alleviates diabetes-associated cognitive dysfunction through modulating neuronal ferroptosis-mediated mitochondrial homeostasis. Antioxid Redox Signal. 2022;37(13):867\u201386.","journal-title":"Antioxid Redox Signal"},{"key":"3178_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.904312","volume":"13","author":"H Ye","year":"2022","unstructured":"Ye H, Wang R, Wei J, Wang Y, Zhang X, Wang L. Bioinformatics analysis identifies potential ferroptosis key gene in type 2 diabetic islet dysfunction. Front Endocrinol. 2022;13:904312.","journal-title":"Front Endocrinol"},{"issue":"8","key":"3178_CR57","doi-asserted-by":"publisher","first-page":"11491","DOI":"10.18632\/aging.202841","volume":"13","author":"Z-W Hu","year":"2021","unstructured":"Hu Z-W, Chen L, Ma R-Q, Wei F-Q, Wen Y-H, Zeng X-L, et al. Comprehensive analysis of ferritin subunits expression and positive correlations with tumor-associated macrophages and T regulatory cells infiltration in most solid tumors. Aging. 2021;13(8):11491.","journal-title":"Aging"},{"issue":"1","key":"3178_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-4157(96)00014-7","volume":"1331","author":"DR Richardson","year":"1997","unstructured":"Richardson DR, Ponka P. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochimica Et Biophysica Acta (BBA)-Rev Biomembr. 1997;1331(1):1\u201340.","journal-title":"Biochimica Et Biophysica Acta (BBA)-Rev Biomembr"},{"key":"3178_CR59","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fnmol.2020.00110","volume":"13","author":"J Chen","year":"2020","unstructured":"Chen J, Wang Y, Wu J, Yang J, Li M, Chen Q. The potential value of targeting ferroptosis in early brain injury after acute CNS disease. Front Mol Neurosci. 2020;13:110.","journal-title":"Front Mol Neurosci"},{"issue":"5704","key":"3178_CR60","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1126\/science.1104742","volume":"306","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090\u20133.","journal-title":"Science"},{"issue":"2","key":"3178_CR61","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1677\/JOE-07-0528","volume":"197","author":"H Kulaksiz","year":"2008","unstructured":"Kulaksiz H, Fein E, Redecker P, Stremmel W, Adler G, Cetin Y. Pancreatic b-cells express hepcidin, an iron-uptake regulatory peptide. J Endocrinol. 2008;197(2):241\u201350.","journal-title":"J Endocrinol"},{"issue":"1","key":"3178_CR62","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jnutbio.2012.02.017","volume":"24","author":"E Aigner","year":"2013","unstructured":"Aigner E, Felder TK, Oberkofler H, Hahne P, Auer S, Soyal S, et al. Glucose acts as a regulator of serum iron by increasing serum hepcidin concentrations. J Nutr Biochem. 2013;24(1):112\u20137.","journal-title":"J Nutr Biochem"},{"issue":"35","key":"3178_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/ange.202300379","volume":"135","author":"F Zeng","year":"2023","unstructured":"Zeng F, Nijiati S, Tang L, Ye J, Zhou Z, Chen X. Ferroptosis detection: from approaches to applications. Angew Chem. 2023;135(35):e202300379.","journal-title":"Angew Chem"},{"key":"3178_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216152","volume":"561","author":"S Zheng","year":"2023","unstructured":"Zheng S, Guan X-Y. Ferroptosis: promising approach for cancer and cancer immunotherapy. Cancer Lett. 2023;561:216152.","journal-title":"Cancer Lett"},{"key":"3178_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.904314","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Yan J, Zhao Q, Zhang Y, Zhang Y. ATF3 promotes ferroptosis in sorafenib-induced cardiotoxicity by suppressing Slc7a11 expression. Front Pharmacol. 2022;13:904314.","journal-title":"Front Pharmacol"},{"issue":"2","key":"3178_CR66","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0005-2760(82)90150-3","volume":"710","author":"F Ursini","year":"1982","unstructured":"Ursini F, Maiorino M, Valente M, Ferri L, Gregolin C. Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. Biochimica et Biophysica Acta (BBA). 1982;710(2):197\u2013211.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"3178_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101470","volume":"60","author":"J He","year":"2022","unstructured":"He J, Li Z, Xia P, Shi A, FuChen X, Zhang J, et al. Ferroptosis and ferritinophagy in diabetes complications. Mol Metab. 2022;60:101470.","journal-title":"Mol Metab"},{"issue":"9","key":"3178_CR68","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1158\/1541-7786.MCR-22-0085","volume":"20","author":"NT Vu","year":"2022","unstructured":"Vu NT, Kim M, Stephenson DJ, MacKnight HP, Chalfant CE. Ceramide kinase inhibition drives ferroptosis and sensitivity to cisplatin in mutant KRAS lung cancer by dysregulating VDAC-mediated mitochondria function. Mol Cancer Res. 2022;20(9):1429\u201342.","journal-title":"Mol Cancer Res"},{"issue":"8","key":"3178_CR69","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.cmet.2021.05.016","volume":"33","author":"E Dierge","year":"2021","unstructured":"Dierge E, Debock E, Guilbaud C, Corbet C, Mignolet E, Mignard L, et al. Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects. Cell Metab. 2021;33(8):1701\u201315.","journal-title":"Cell Metab"},{"issue":"3","key":"3178_CR70","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.bbrc.2016.08.124","volume":"478","author":"H Yuan","year":"2016","unstructured":"Yuan H, Li X, Zhang X, Kang R, Tang D. Identification of ACSL4 as a biomarker and contributor of ferroptosis. Biochem Biophys Res Commun. 2016;478(3):1338\u201343.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3178_CR71","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Kagan VE, Mao G, Qu F, Angeli JPF, Doll S, Croix CS, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13(1):81\u201390.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"3178_CR72","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/ars.2017.7115","volume":"29","author":"M Maiorino","year":"2018","unstructured":"Maiorino M, Conrad M, Ursini F. GPx4, lipid peroxidation, and cell death: discoveries, rediscoveries, and open issues. Antioxid Redox Signal. 2018;29(1):61\u201374.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"3178_CR73","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/0304-4165(85)90182-5","volume":"839","author":"F Ursini","year":"1985","unstructured":"Ursini F, Maiorino M, Gregolin C. The selenoenzyme phospholipid hydroperoxide glutathione peroxidase. Biochimica et Biophysica Acta (BBA)-Gen Sub. 1985;839(1):62\u201370.","journal-title":"Biochimica et Biophysica Acta (BBA)-Gen Sub"},{"issue":"1\u20132","key":"3178_CR74","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1\u20132):317\u201331.","journal-title":"Cell"},{"key":"3178_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-566501-8.50009-2","volume-title":"Free radical mechanisms of lipid damage and consequences for cellular membranes","author":"JF Mead","year":"1976","unstructured":"Mead JF. Free radical mechanisms of lipid damage and consequences for cellular membranes. Cambridge: Academic Press; 1976."},{"issue":"4","key":"3178_CR76","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bbalip.2014.10.002","volume":"1851","author":"H Kuhn","year":"2015","unstructured":"Kuhn H, Banthiya S, Van Leyen K. Mammalian lipoxygenases and their biological relevance. Biochimica et Biophysica Acta (BBA). 2015;1851(4):308\u201330.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"3","key":"3178_CR77","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.cell.2017.10.006","volume":"171","author":"FY Ling","year":"2017","unstructured":"Ling FY, Stockwell BR. Transforming lipoxygenases: PE-specific enzymes in disguise. Cell. 2017;171(3):501\u20132.","journal-title":"Cell"},{"issue":"15","key":"3178_CR78","doi-asserted-by":"publisher","first-page":"5095","DOI":"10.1021\/ja00353a039","volume":"105","author":"B Maillard","year":"1983","unstructured":"Maillard B, Ingold K, Scaiano J. Rate constants for the reactions of free radicals with oxygen in solution. J Am Chem Soc. 1983;105(15):5095\u20139.","journal-title":"J Am Chem Soc"},{"issue":"10","key":"3178_CR79","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1021\/cr200084z","volume":"111","author":"H Yin","year":"2011","unstructured":"Yin H, Xu L, Porter NA. Free radical lipid peroxidation: mechanisms and analysis. Chem Rev. 2011;111(10):5944\u201372.","journal-title":"Chem Rev"},{"issue":"3","key":"3178_CR80","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1021\/cr040077w","volume":"107","author":"Z Cheng","year":"2007","unstructured":"Cheng Z, Li Y. What is responsible for the initiating chemistry of iron-mediated lipid peroxidation: an update. Chem Rev. 2007;107(3):748\u201366.","journal-title":"Chem Rev"},{"issue":"2","key":"3178_CR81","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Angeli JPF, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273\u201385.","journal-title":"Cell"},{"issue":"4","key":"3178_CR82","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/apha.12256","volume":"210","author":"J Hansen","year":"2014","unstructured":"Hansen J, Moen I, Mandrup-Poulsen T. Iron: the hard player in diabetes pathophysiology. Acta Physiol. 2014;210(4):717\u201332.","journal-title":"Acta Physiol"},{"issue":"9","key":"3178_CR83","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.3945\/jn.113.177808","volume":"143","author":"L Sun","year":"2013","unstructured":"Sun L, Zong G, Pan A, Ye X, Li H, Yu Z, et al. Elevated plasma ferritin is associated with increased incidence of type 2 diabetes in middle-aged and elderly Chinese adults. J Nutr. 2013;143(9):1459\u201365.","journal-title":"J Nutr"},{"issue":"1","key":"3178_CR84","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2337\/db10-0593","volume":"60","author":"J Huang","year":"2011","unstructured":"Huang J, Jones D, Luo B, Sanderson M, Soto J, Abel ED, et al. Iron overload and diabetes risk: a shift from glucose to fatty acid oxidation and increased hepatic glucose production in a mouse model of hereditary hemochromatosis. Diabetes. 2011;60(1):80\u20137.","journal-title":"Diabetes"},{"issue":"1","key":"3178_CR85","doi-asserted-by":"publisher","first-page":"1930261","DOI":"10.1155\/2017\/1930261","volume":"2017","author":"J Wang","year":"2017","unstructured":"Wang J, Wang H. Oxidative stress in pancreatic beta cell regeneration. Oxid Med Cell Longev. 2017;2017(1):1930261.","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"3178_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0506-0","volume":"9","author":"A Bruni","year":"2018","unstructured":"Bruni A, Pepper AR, Pawlick RL, Gala-Lopez B, Gamble AF, Kin T, et al. Ferroptosis-inducing agents compromise in vitro human islet viability and function. Cell Death Dis. 2018;9(6):595.","journal-title":"Cell Death Dis"},{"issue":"2","key":"3178_CR87","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4239\/wjd.v12.i2.124","volume":"12","author":"E-F Luo","year":"2021","unstructured":"Luo E-F, Li H-X, Qin Y-H, Qiao Y, Yan G-L, Yao Y-Y, et al. Role of ferroptosis in the process of diabetes-induced endothelial dysfunction. World J Diabetes. 2021;12(2):124.","journal-title":"World J Diabetes"},{"key":"3178_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2019.121390","volume":"384","author":"S Wei","year":"2020","unstructured":"Wei S, Qiu T, Yao X, Wang N, Jiang L, Jia X, et al. Arsenic induces pancreatic dysfunction and ferroptosis via mitochondrial ROS-autophagy-lysosomal pathway. J Hazard Mater. 2020;384:121390.","journal-title":"J Hazard Mater"},{"key":"3178_CR89","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.freeradbiomed.2018.12.011","volume":"131","author":"J Du","year":"2019","unstructured":"Du J, Wang T, Li Y, Zhou Y, Wang X, Yu X, et al. DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin. Free Radic Biol Med. 2019;131:356\u201369.","journal-title":"Free Radic Biol Med"},{"key":"3178_CR90","doi-asserted-by":"publisher","first-page":"1425955","DOI":"10.3389\/fphar.2024.1425955","volume":"15","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Li L, Fu W, Fu Z, Si M, Wu S, et al. Therapeutic effects of natural compounds against diabetic complications via targeted modulation of ferroptosis. Front Pharmacol. 2024;15:1425955.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3178_CR91","doi-asserted-by":"publisher","first-page":"6678662","DOI":"10.1155\/2021\/6678662","volume":"2021","author":"H Yi","year":"2021","unstructured":"Yi H, Peng H, Wu X, Xu X, Kuang T, Zhang J, et al. The therapeutic effects and mechanisms of quercetin on metabolic diseases: pharmacological data and clinical evidence. Oxid Med Cell Longev. 2021;2021(1):6678662.","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"3178_CR92","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","volume":"19","author":"M Foretz","year":"2023","unstructured":"Foretz M, Guigas B, Viollet B. Metformin: update on mechanisms of action and repurposing potential. Nat Rev Endocrinol. 2023;19(8):460\u201376.","journal-title":"Nat Rev Endocrinol"},{"issue":"17","key":"3178_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179453","volume":"22","author":"S-K Hsu","year":"2021","unstructured":"Hsu S-K, Cheng K-C, Mgbeahuruike MO, Lin Y-H, Wu C-Y, Wang H-MD, et al. New insight into the effects of metformin on diabetic retinopathy, aging and cancer: nonapoptotic cell death, immunosuppression, and effects beyond the AMPK pathway. Int J Mol Sci. 2021;22(17):9453.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3178_CR94","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41556-020-0461-8","volume":"22","author":"H Lee","year":"2020","unstructured":"Lee H, Zandkarimi F, Zhang Y, Meena JK, Kim J, Zhuang L, et al. Energy-stress-mediated AMPK activation inhibits ferroptosis. Nat Cell Biol. 2020;22(2):225\u201334.","journal-title":"Nat Cell Biol"},{"key":"3178_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108560","author":"F Yue","year":"2023","unstructured":"Yue F, Shi Y, Wu S, Xing L, He D, Wei L, et al. Metformin alleviates hepatic iron overload and ferroptosis through AMPK-ferroportin pathway in HFD-induced NAFLD. IScience. 2023. https:\/\/doi.org\/10.1016\/j.isci.2023.108560.","journal-title":"IScience"},{"key":"3178_CR96","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.freeradbiomed.2021.01.033","volume":"165","author":"W-Q Ma","year":"2021","unstructured":"Ma W-Q, Sun X-J, Zhu Y, Liu N-F. Metformin attenuates hyperlipidaemia-associated vascular calcification through anti-ferroptotic effects. Free Radic Biol Med. 2021;165:229\u201342.","journal-title":"Free Radic Biol Med"},{"key":"3178_CR97","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.89045.4","author":"F Wang","year":"2024","unstructured":"Wang F, Liu X, Huang F, Zhou Y, Wang X, Song Z, et al. Gut microbiota-derived gamma-aminobutyric acid from metformin treatment reduces hepatic ischemia\/reperfusion injury through inhibiting ferroptosis. Elife. 2024. https:\/\/doi.org\/10.7554\/eLife.89045.4.","journal-title":"Elife"},{"issue":"15","key":"3178_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30153112","volume":"30","author":"M Stielow","year":"2025","unstructured":"Stielow M, Fija\u0142kowski \u0141, Alaburda A, Grze\u015bk G, Grze\u015bk E, Nowaczyk J, et al. SGLT2 inhibitors: from molecular mechanisms to clinical outcomes in cardiology and diabetology. Molecules. 2025;30(15):3112.","journal-title":"Molecules"},{"issue":"6","key":"3178_CR99","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s41401-022-01031-0","volume":"44","author":"J-x Han","year":"2023","unstructured":"Han J-x, Luo L-l, Wang Y-c, Miyagishi M, Kasim V, Wu S-r. SGLT2 inhibitor empagliflozin promotes revascularization in diabetic mouse hindlimb ischemia by inhibiting ferroptosis. Acta Pharmacol Sin. 2023;44(6):1161\u201374.","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"3178_CR100","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00210-022-02243-1","volume":"395","author":"S Ma","year":"2022","unstructured":"Ma S, He L-L, Zhang G-R, Zuo Q-J, Wang Z-L, Zhai J-L, et al. Canagliflozin mitigates ferroptosis and ameliorates heart failure in rats with preserved ejection fraction. Naunyn-Schmiedebergs Arch Pharmacol. 2022;395(8):945\u201362.","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"3178_CR101","first-page":"106","volume":"11","author":"M Packer","year":"2023","unstructured":"Packer M. Potential interactions when prescribing SGLT2 inhibitors and intravenous iron in combination in heart failure. Heart Fail. 2023;11(1):106\u201314.","journal-title":"Heart Fail"},{"key":"3178_CR102","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-03918-1","author":"A Pandey","year":"2025","unstructured":"Pandey A, Rath G, Chawala R, Goyal AK. A comprehensive review on liraglutide and novel nanocarrier-based systems for the effective delivery of liraglutide. Naunyn-Schmiedebergs Arch Pharmacol. 2025. https:\/\/doi.org\/10.1007\/s00210-025-03918-1.","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"3178_CR103","doi-asserted-by":"publisher","first-page":"8334","DOI":"10.1080\/21655979.2022.2051858","volume":"13","author":"J-X Song","year":"2022","unstructured":"Song J-X, An J-R, Chen Q, Yang X-Y, Jia C-L, Xu S, et al. Liraglutide attenuates hepatic iron levels and ferroptosis in db\/db mice. Bioengineered. 2022;13(4):8334\u201348.","journal-title":"Bioengineered"},{"issue":"2","key":"3178_CR104","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11064-021-03442-7","volume":"47","author":"J-R An","year":"2022","unstructured":"An J-R, Su J-N, Sun G-Y, Wang Q-F, Fan Y-D, Jiang N, et al. Liraglutide alleviates cognitive deficit in db\/db mice: involvement in oxidative stress, iron overload, and ferroptosis. Neurochem Res. 2022;47(2):279\u201394.","journal-title":"Neurochem Res"},{"issue":"1","key":"3178_CR105","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s10020-023-00721-7","volume":"29","author":"T Guo","year":"2023","unstructured":"Guo T, Yan W, Cui X, Liu N, Wei X, Sun Y, et al. Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK\/ACC signaling and inhibiting ferroptosis. Mol Med. 2023;29(1):132.","journal-title":"Mol Med"},{"issue":"10","key":"3178_CR106","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.3390\/nu12102954","volume":"12","author":"D Li","year":"2020","unstructured":"Li D, Jiang C, Mei G, Zhao Y, Chen L, Liu J, et al. Quercetin alleviates ferroptosis of pancreatic \u03b2 cells in type 2 diabetes. Nutrients. 2020;12(10):2954.","journal-title":"Nutrients"},{"key":"3178_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110614","volume":"106","author":"W Yan","year":"2023","unstructured":"Yan W, Guo T, Liu N, Cui X, Wei X, Sun Y, et al. Erythropoietin ameliorates cognitive deficits by improving hippocampal and synaptic damage in streptozotocin-induced diabetic mice. Cell Signal. 2023;106:110614.","journal-title":"Cell Signal"},{"key":"3178_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2023.114414","volume":"365","author":"T Guo","year":"2023","unstructured":"Guo T, Yu Y, Yan W, Zhang M, Yi X, Liu N, et al. Erythropoietin ameliorates cognitive dysfunction in mice with type 2 diabetes mellitus via inhibiting iron overload and ferroptosis. Exp Neurol. 2023;365:114414.","journal-title":"Exp Neurol"},{"key":"3178_CR109","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jchromb.2014.08.032","volume":"969","author":"R Deng","year":"2014","unstructured":"Deng R, Xu Y, Feng F, Liu W. Identification of poliumoside metabolites in rat feces by high performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry. J Chromatogr B. 2014;969:285\u201396.","journal-title":"J Chromatogr B"},{"key":"3178_CR110","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.693983","volume":"12","author":"J-N Zheng","year":"2021","unstructured":"Zheng J-N, Zhuo J-Y, Nie J, Liu Y-L, Chen B-Y, Wu A-Z, et al. Phenylethanoid glycosides from callicarpa kwangtungensis chun attenuate TNF-\u03b1-Induced cell damage by inhibiting NF-\u03baB pathway and enhancing Nrf2 pathway in A549 cells. Front Pharmacol. 2021;12:693983.","journal-title":"Front Pharmacol"},{"key":"3178_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155342","volume":"125","author":"C-Y Xu","year":"2024","unstructured":"Xu C-Y, Xu C, Xu Y-N, Du S-Q, Dai Z-H, Jin S-Q, et al. Poliumoside protects against type 2 diabetes-related osteoporosis by suppressing ferroptosis via activation of the Nrf2\/GPX4 pathway. Phytomedicine. 2024;125:155342.","journal-title":"Phytomedicine"},{"issue":"05","key":"3178_CR112","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1055\/s-0030-1255448","volume":"36","author":"G Lippi","year":"2010","unstructured":"Lippi G, Franchini M, Favaloro EJ. Thrombotic complications of erythropoiesis-stimulating agents. Semin Thromb Hemost. 2010;36(05):537\u201349.","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"3178_CR113","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00268-008-9836-x","volume":"33","author":"M Li","year":"2009","unstructured":"Li M, Marin-Muller C, Bharadwaj U, Chow KH, Yao Q, Chen C. MicroRNAs: control and loss of control in human physiology and disease. World J Surg. 2009;33(4):667\u201384.","journal-title":"World J Surg"},{"issue":"1","key":"3178_CR114","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10495-023-01890-w","volume":"29","author":"S Jin","year":"2024","unstructured":"Jin S, Liu P-S, Zheng D, Xie X. The interplay of miRNAs and ferroptosis in diseases related to iron overload. Apoptosis. 2024;29(1):45\u201365.","journal-title":"Apoptosis"},{"key":"3178_CR115","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.metabol.2018.07.001","volume":"87","author":"H Yaribeygi","year":"2018","unstructured":"Yaribeygi H, Katsiki N, Behnam B, Iranpanah H, Sahebkar A. Micrornas and type 2 diabetes mellitus: molecular mechanisms and the effect of antidiabetic drug treatment. Metabolism. 2018;87:48\u201355.","journal-title":"Metabolism"},{"issue":"4","key":"3178_CR116","doi-asserted-by":"publisher","first-page":"8238","DOI":"10.1080\/21655979.2022.2049471","volume":"13","author":"X Tang","year":"2022","unstructured":"Tang X, Li X, Zhang D, Han W. Astragaloside-IV alleviates high glucose-induced ferroptosis in retinal pigment epithelial cells by disrupting the expression of miR-138-5p\/Sirt1\/Nrf2. Bioengineered. 2022;13(4):8238\u201353.","journal-title":"Bioengineered"},{"issue":"2","key":"3178_CR117","doi-asserted-by":"publisher","first-page":"12555","DOI":"10.1080\/21655979.2021.2010369","volume":"12","author":"Z Zhu","year":"2021","unstructured":"Zhu Z, Duan P, Song H, Zhou R, Chen T. Downregulation of circular RNA PSEN1 ameliorates ferroptosis of the high glucose treated retinal pigment epithelial cells via miR-200b-3p\/cofilin-2 axis. Bioengineered. 2021;12(2):12555\u201367.","journal-title":"Bioengineered"},{"issue":"1","key":"3178_CR118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280548","volume":"18","author":"Y Huang","year":"2023","unstructured":"Huang Y, Peng J, Liang Q. Identification of key ferroptosis genes in diabetic retinopathy based on bioinformatics analysis. PLoS ONE. 2023;18(1):e0280548.","journal-title":"PLoS ONE"},{"key":"3178_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2022.103488","volume":"150","author":"MM Alrashed","year":"2022","unstructured":"Alrashed MM, Alharbi H, Alshehry AS, Ahmad M, Aloahd MS. MiR-624-5p enhances NLRP3 augmented gemcitabine resistance via EMT\/IL-1\u03b2\/Wnt\/\u03b2-catenin signaling pathway in ovarian cancer. J Reprod Immunol. 2022;150:103488.","journal-title":"J Reprod Immunol"},{"issue":"3","key":"3178_CR120","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10735-022-10070-0","volume":"53","author":"J Zhou","year":"2022","unstructured":"Zhou J, Sun C, Dong X, Wang H. A novel miR-338-3p\/SLC1A5 axis reprograms retinal pigment epithelium to increases its resistance to high glucose-induced cell ferroptosis. J Mol Histol. 2022;53(3):561\u201371.","journal-title":"J Mol Histol"},{"issue":"1","key":"3178_CR121","doi-asserted-by":"publisher","first-page":"9004738","DOI":"10.1155\/2022\/9004738","volume":"2022","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhang Z, Yang J, Wang J, Wu Y, Zhu R, et al. lncRNA ZFAS1 Positively Facilitates Endothelial Ferroptosis via miR-7-5p\/ACSL4 Axis in Diabetic Retinopathy. Oxid Med Cell Longev. 2022;2022(1):9004738.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"3178_CR122","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00592-022-01961-5","volume":"60","author":"Q Li","year":"2023","unstructured":"Li Q, Meng X, Hua Q. Circ ASAP2 decreased inflammation and ferroptosis in diabetic nephropathy through SOX2\/SLC7A11 by miR-770-5p. Acta Diabetol. 2023;60(1):29\u201342.","journal-title":"Acta Diabetol"},{"key":"3178_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2024.112384","volume":"594","author":"D Wang","year":"2024","unstructured":"Wang D, Zhang L, Nan J, Wan S, Luo J, Li X, et al. High glucose elevates intracellular calcium level and induces ferroptosis in glomerular endothelial cells through the miR-223-3p\/ITPR3 pathway. Mol Cell Endocrinol. 2024;594:112384.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"3178_CR124","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2025.2490200","volume":"47","author":"C Chen","year":"2025","unstructured":"Chen C, Liu X, Zhu S, Wang Y, Ma Y, Hu Z, et al. Circ-0069561 as a novel diagnostic biomarker for progression of diabetic kidney disease. Ren Fail. 2025;47(1):2490200.","journal-title":"Ren Fail"},{"issue":"1","key":"3178_CR125","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s41065-025-00453-0","volume":"162","author":"Y Cheng","year":"2025","unstructured":"Cheng Y, Wan J, Xu Y, Liu S, Li L, Zhou J, et al. RBM15 promotes hypoxia\/reoxygenation-induced ferroptosis in human cardiomyocytes by mediating m6A modification of ACSL4. Hereditas. 2025;162(1):135.","journal-title":"Hereditas"},{"issue":"1","key":"3178_CR126","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s41065-025-00385-9","volume":"162","author":"J Wang","year":"2025","unstructured":"Wang J, Li X, Geng J, Wang R, Ma G, Liu P. Identification of biomarkers and mechanism exploration of ferroptosis related genes regulated by m6A in type 2 diabetes mellitus. Hereditas. 2025;162(1):24.","journal-title":"Hereditas"},{"key":"3178_CR127","doi-asserted-by":"publisher","DOI":"10.1111\/dme.70033","author":"Q Liao","year":"2025","unstructured":"Liao Q, Li Y, Cui M, Liu M. m6A demethylase ALKBH5 reduces ferroptosis in diabetic retinopathy through the m6A-YTHDF1-ACSL4 axis. Diabet Med. 2025. https:\/\/doi.org\/10.1111\/dme.70033.","journal-title":"Diabet Med"},{"issue":"1","key":"3178_CR128","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13098-022-00852-7","volume":"14","author":"S Zhang","year":"2022","unstructured":"Zhang S, Liu X, Wang J, Yuan F, Liu Y. Targeting ferroptosis with miR-144-3p to attenuate pancreatic \u03b2 cells dysfunction via regulating USP22\/SIRT1 in type 2 diabetes. Diabetol Metab Syndr. 2022;14(1):89.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"3178_CR129","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s12672-025-03421-2","volume":"16","author":"C Zhao","year":"2025","unstructured":"Zhao C, Wang T, Lu Y, Zhou Y, Chen J, Ju R. Copper-overload promotes ferroptosis in cervical cancer cells by upregulating HMOX1 expression. Discover Oncology. 2025;16(1):1549.","journal-title":"Discover Oncology"},{"key":"3178_CR130","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2022.02.017","volume":"182","author":"X Guo","year":"2022","unstructured":"Guo X, Jin X, Han K, Kang S, Tian S, Lv X, et al. Iron promotes neurological function recovery in mice with ischemic stroke through endogenous repair mechanisms. Free Radic Biol Med. 2022;182:59\u201372.","journal-title":"Free Radic Biol Med"},{"key":"3178_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102035","volume":"91","author":"Y Wang","year":"2023","unstructured":"Wang Y, Lv M-n, Zhao W-j. Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases. Ageing Res Rev. 2023;91:102035.","journal-title":"Ageing Res Rev"},{"key":"3178_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2022.128911","volume":"74","author":"J You","year":"2022","unstructured":"You J, Yang W, Ma R, Xia A, Zhang G, Fang Z, et al. Discovery of 2-vinyl-10H-phenothiazine derivatives as a class of ferroptosis inhibitors with minimal human Ether-a-go-go related gene (hERG) activity for the treatment of DOX-induced cardiomyopathy. Bioorg Med Chem Lett. 2022;74:128911.","journal-title":"Bioorg Med Chem Lett"},{"key":"3178_CR133","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fnagi.2020.00196","volume":"12","author":"A Ashraf","year":"2020","unstructured":"Ashraf A, So P-W. Spotlight on ferroptosis: iron-dependent cell death in Alzheimer\u2019s disease. Front Aging Neurosci. 2020;12:196.","journal-title":"Front Aging Neurosci"},{"key":"3178_CR134","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18366","author":"N Lecornec","year":"2022","unstructured":"Lecornec N, Castex MP, R\u00e9guerre Y, Moreau P, Marie I, Gar\u00e7on L, et al. Agranulocytosis in patients with Diamond-Blackfan anaemia (DBA) treated with deferiprone for post-transfusion iron overload: a retrospective study of the French DBA cohort. Br J Haematol. 2022. https:\/\/doi.org\/10.1111\/bjh.18366.","journal-title":"Br J Haematol"},{"issue":"8","key":"3178_CR135","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1021\/acs.jmedchem.0c00137","volume":"63","author":"W Chen","year":"2020","unstructured":"Chen W, Yuan X, Li Z, Lu Z, Kong S, Jiang H, et al. CN128: a new orally active hydroxypyridinone iron chelator. J Med Chem. 2020;63(8):4215\u201326.","journal-title":"J Med Chem"},{"key":"3178_CR136","doi-asserted-by":"publisher","first-page":"1407335","DOI":"10.3389\/fphar.2024.1407335","volume":"15","author":"L Zhang","year":"2024","unstructured":"Zhang L, Luo YL, Xiang Y, Bai XY, Qiang RR, Zhang X, et al. Ferroptosis inhibitors: past, present and future. Front Pharmacol. 2024;15:1407335.","journal-title":"Front Pharmacol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03178-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03178-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03178-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T04:03:25Z","timestamp":1760587405000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03178-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":136,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3178"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03178-y","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the submission and publication of this revised manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"982"}}